GlassScriptPhysician profile
Alejandro A Aldana
NPI 1295739274
$13,190.34
in general payments reported to CMS, 2019-2025
54 companies · $3,923 in 2025
The $3,923 reported for 2025 was more than what 80% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,495 · 2020: $376 · 2021: $698 · 2022: $851 · 2023: $3,513 · 2024: $2,334 · 2025: $3,923.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,552 · Travel and Lodging: $4,204 · Entertainment: $13.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,552.31 |
| Travel and Lodging | $4,203.88 |
| Entertainment | $13.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $5,060.09 | 2023-2025 | Indigo System, Penumbra System |
| Inari Medical, INC. | $1,712.09 | 2019-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Novartis Pharmaceuticals Corporation | $655.58 | 2019-2025 | |
| Stryker Corporation | $566.98 | 2025 | Flowtriever |
| Janssen Pharmaceuticals, INC | $523.35 | 2019-2024 | Xarelto |
| Medtronic, INC. | $500.29 | 2023-2025 | Abre, In.Pact Admiral, Venaseal |
| Pfizer INC. | $384.44 | 2019-2025 | |
| Amgen INC. | $328.36 | 2019-2025 | Repatha, Repatha |
| Abiomed | $267.30 | 2019-2024 | Impella |
| Impulse Dynamics (USA) INC. | $256.71 | 2022-2023 | Optimizer |
| Celonova Biosciences, INC. | $206.34 | 2019 | |
| Boston Scientific Corporation | $201.43 | 2020-2023 | Watchman Access System |
| Sanofi-Aventis U.S. LLC | $196.98 | 2019-2023 | |
| E.R. Squibb & Sons, L.L.C. | $189.73 | 2019-2024 | Camzyos |
| Astrazeneca Pharmaceuticals LP | $187.87 | 2019-2025 | Wainua |
Show all 54 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alejandro Aldana listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.